Stock NEUN NEUROGENESIS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Neurogenesis, Inc.

Equities

NEUN

US64124F3010

Market Closed - OTC Markets
Other stock markets
 12:19:23 13/06/2024 am IST 		5-day change 1st Jan Change
0.0001 USD -.--% Intraday chart for Neurogenesis, Inc. -.--% -.--%
2023 Neurogenesis, Inc. Doses First Patients in Phase 1/2 Trial of NGN-401 for the Treatment of Female Pediatric Patients with Rett Syndrome CI
2021 Neurogene Inc. and University of Edinburgh Announces Research Collaboration to Advance Next Generation Gene Therapies CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
NEUROGENESIS, INC. - -.--%-.--%-.--%-.--%-97.14% 8.23K - - -
  1. Stock Market
  2. Equities
  3. NEUN Stock
  4. Charts Neurogenesis, Inc.
  5. Relative Strength Chart